Literature DB >> 10211518

Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients.

J G Guillem1, J Puig-La Calle, C Cellini, M Murray, J Ng, M Fazzari, P B Paty, S H Quan, W D Wong, A M Cohen.   

Abstract

PURPOSE: Although the criteria for clinical diagnosis of hereditary nonpolyposis colorectal cancer are not fully agreed on, young age seems to be a common trait. The purpose of this study is to identify clinicopathologic features of hereditary nonpolyposis colorectal cancer in early age-of-onset colorectal cancer patients stratified as a function of family cancer history.
METHODS: Two hundred thirty consecutive colorectal cancer patients 40 years or older at time of diagnosis were registered into an ongoing database during a ten-year period. Accurate family history was obtained via medical records, telephone calls, and questionnaires on 146 patients. According to extent of family history of cancer, patients were stratified into seven groups: 1) fulfilling Amsterdam criteria, 2) fulfilling less strict criteria, 3) having at least one first-degree relative with colorectal cancer, 4) having at least one distant relative with colorectal cancer, 5) having at least one first-degree relative with any cancer, 6) having at least one distant relative with any cancer, 7) having no family history of cancer.
RESULTS: Twenty-two of 146 patients fulfilled Amsterdam and less strict hereditary nonpolyposis colorectal cancer criteria (15 percent). These hereditary nonpolyposis colorectal cancer patients were significantly younger (31 vs. 35 years; P = 0.0003) and had more metachronous colorectal cancer (27 percent vs. 2 percent; P = 0.007) and less colorectal cancer with nodal or metastatic spread than the non-hereditary nonpolyposis colorectal cancer patients (35 percent vs. 65 percent; P = 0.01).
CONCLUSION: Precise familial cancer assessment in early age-of-onset colorectal cancer increases the yield of hereditary nonpolyposis colorectal cancer diagnosis. Because of the frequent development of metachronous colorectal cancer and favorable prognosis, extensive rather than segmental surgery should be considered in early age-of-onset colorectal cancer patients belonging to hereditary nonpolyposis colorectal cancer families.

Entities:  

Mesh:

Year:  1999        PMID: 10211518     DOI: 10.1007/bf02235180

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups.

Authors:  J M Chiang; C Y Yeh; C R Changchien; J S Chen; R Tang; J R Chen
Journal:  Int J Colorectal Dis       Date:  2010-06-08       Impact factor: 2.571

2.  Clinicopathological and molecular genetic analysis of HNPCC in China.

Authors:  Ding-Cun Luo; Qi Cai; Meng-Hong Sun; Yao-Zhong Ni; Shi-Chang Ni; Zhe-Jing Chen; Xiao-Yang Li; Chong-Wei Tao; Xue-Miao Zhang; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.

Authors:  San-Jun Cai; Ye Xu; Guo-Xiang Cai; Peng Lian; Zu-Qing Guan; Shan-Jing Mo; Meng-Hong Sun; Qi Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Precancerous lesions in colorectal cancer.

Authors:  Fayez Sandouk; Feras Al Jerf; M H D Bassel Al-Halabi
Journal:  Gastroenterol Res Pract       Date:  2013-05-14       Impact factor: 2.260

5.  Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience.

Authors:  Phillipo L Chalya; Mabula D McHembe; Joseph B Mabula; Peter F Rambau; Hyasinta Jaka; Mheta Koy; Eliasa Mkongo; Nestory Masalu
Journal:  World J Surg Oncol       Date:  2013-04-18       Impact factor: 2.754

6.  Frequency of all types of colorectal tumors in the patients referred to selected hospitals in tehran.

Authors:  Farzaneh Golfam; Parisa Golfam; Zeinab Neghabi
Journal:  Iran Red Crescent Med J       Date:  2013-06-05       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.